The world’s largest vaccination campaign against the new coronavirus will begin on Saturday when India begins vaccinating three million million of its front-line workers. In the first phase, two indigenous vaccines, Covaxin and Covishield, will be administered to the priority groups. More than one crore and 5.27 lakh people have …
Read More »Oxford COVID-19 Covishield Vaccine, Bharat Biotech’s Covaxin Gain DCGI Approval for Emergency Use
The indigenous vaccine developed by Bharat Biotech with the Indian Council for Medical Research (ICMR) will be used as a ‘backup’, only if the country needs additional doses to vaccinate large numbers of people, particularly given the possibility of an increase sudden triggered by the UK variant. And, unlike the …
Read More »Oxford COVID-19 Covishield Vaccine, Bharat Biotech’s Covaxin Gain DCGI Approval for Emergency Use
The indigenous vaccine developed by Bharat Biotech with the Indian Council for Medical Research (ICMR) will be used as a ‘backup’, only if the country needs additional doses to vaccinate large numbers of people, particularly given the possibility of an increase sudden triggered by the UK variant. And, unlike the …
Read More »Serum Institute expects regulatory approval for Oxford coronavirus vaccine in a few days
The Serum Institute of India, which is manufacturing and testing the Oxford / AstraZeneca coronavirus vaccine in the country, said Monday. awaited regulatory approval to take in a few days. Serum CEO Adar Poonawalla said the vaccine, called Covishield in India, should be licensed by January. “The emergency use authorization …
Read More »3 Covid-19 Vaccine Developers Seek Emergency Use Approval In India
Written by Kaunain Sheriff M, Amitabh Sinha | New Delhi, Pune | Updated: December 9, 2020 10:02:09 am Vials of Covishield, the Indian version of the AstraZeneca-Oxford vaccine, at the Serum Institute of India in Pune, India. (Reuters photo) Three vaccine developers have submitted applications to the Central Drug Standards …
Read More »